Schroder Investment Management Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $201M | Sell |
4,708,211
-2,543,796
| -35% | -$138M | 0.14% | 139 |
|
|
2026
Q1 | $455M | Sell |
7,252,007
-1,097,634
| -13% | -$87.8M | 0.37% | 56 |
|
|
2025
Q4 | $796M | Buy |
8,349,641
+538,723
| +7% | +$52.8M | 0.6% | 29 |
|
|
2025
Q3 | $763M | Sell |
7,810,918
-552,139
| -7% | -$57.2M | 0.6% | 29 |
|
|
2025
Q2 | $898M | Buy |
8,363,057
+940,875
| +13% | +$95.2M | 0.76% | 22 |
|
|
2025
Q1 | $749M | Sell |
7,422,182
-59,880
| -0.8% | -$6.03M | 0.76% | 23 |
|
|
2024
Q4 | $668M | Buy |
7,482,062
+1,281,005
| +21% | +$113M | 0.64% | 29 |
|
|
2024
Q3 | $520M | Buy |
6,201,057
+1,838,247
| +42% | +$145M | 0.53% | 37 |
|
|
2024
Q2 | $336M | Buy |
4,362,810
+582,633
| +15% | +$42.6M | 0.37% | 57 |
|
|
2024
Q1 | $259M | Buy |
3,780,177
+783,818
| +26% | +$50.4M | 0.3% | 66 |
|
|
2023
Q4 | $173M | Buy |
2,996,359
+100,448
| +3% | +$5.36M | 0.22% | 89 |
|
|
2023
Q3 | $153M | Buy |
2,895,911
+328,361
| +13% | +$17.2M | 0.23% | 88 |
|
|
2023
Q2 | $139M | Buy |
2,567,550
+475,071
| +23% | +$24.8M | 0.2% | 93 |
|
|
2023
Q1 | $105M | Sell |
2,092,479
-46,441
| -2% | -$2.19M | 0.16% | 134 |
|
|
2022
Q4 | $99M | Buy |
2,138,920
+197,171
| +10% | +$8.54M | 0.16% | 138 |
|
|
2022
Q3 | $75.2M | Buy |
1,941,749
+1,265,439
| +187% | +$50.8M | 0.12% | 163 |
|
|
2022
Q2 | $25.2M | Buy |
676,310
+107,371
| +19% | +$4.37M | 0.04% | 402 |
|
|
2022
Q1 | $25.4M | Sell |
568,939
-20,417
| -3% | -$885K | 0.03% | 441 |
|
|
2021
Q4 | $25M | Buy |
589,356
+58,142
| +11% | +$2.44M | 0.03% | 426 |
|
|
2021
Q3 | $23M | Buy |
531,214
+44,276
| +9% | +$1.96M | 0.04% | 451 |
|
|
2021
Q2 | $20.8M | Buy |
486,938
+61,265
| +14% | +$2.58M | 0.03% | 508 |
|
|
2021
Q1 | $16.5M | Buy |
425,673
+40,140
| +10% | +$1.52M | 0.02% | 558 |
|
|
2020
Q4 | $13.9M | Sell |
385,533
-454,618
| -54% | -$16.4M | 0.02% | 560 |
|
|
2020
Q3 | $32.3M | Buy |
840,151
+122,273
| +17% | +$4.71M | 0.05% | 330 |
|
|
2020
Q2 | $25.2M | Buy |
717,878
+95,851
| +15% | +$3.45M | 0.05% | 367 |
|
|
2020
Q1 | $20.5M | Sell |
622,027
-86,523
| -12% | -$3.38M | 0.04% | 370 |
|
|
2019
Q4 | $32M | Buy |
708,550
+64,356
| +10% | +$2.69M | 0.05% | 385 |
|
|
2019
Q3 | $26M | Buy |
644,194
+71,372
| +12% | +$3.02M | 0.05% | 407 |
|
|
2019
Q2 | $24.6M | Buy |
572,822
+203,647
| +55% | +$7.83M | 0.04% | 398 |
|
|
2019
Q1 | $14.2M | Buy |
369,175
+352,056
| +2,057% | +$13.4M | 0.03% | 515 |
|
|
2018
Q4 | $605 | Buy |
17,119
+3,594
| +27% | +$130K | ﹤0.01% | 969 |
|
|
2018
Q3 | $521K | Buy |
13,525
+147
| +1% | +$5.13K | ﹤0.01% | 1020 |
|
|
2018
Q2 | $435K | Sell |
13,378
-153,544
| -92% | -$4.63M | ﹤0.01% | 1063 |
|
|
2018
Q1 | $4.56M | Hold |
166,922
| – | – | 0.01% | 741 |
|
|
2017
Q4 | $4.14M | Sell |
166,922
-86,499
| -34% | -$2.39M | 0.01% | 804 |
|
|
2017
Q3 | $7.28M | Sell |
253,421
-21,759
| -8% | -$601K | 0.01% | 691 |
|
|
2017
Q2 | $7.66M | Buy |
275,180
+8,623
| +3% | +$229K | 0.01% | 655 |
|
|
2017
Q1 | $6.52M | Buy |
266,557
+39,931
| +18% | +$971K | 0.01% | 676 |
|
|
2016
Q4 | $4.9M | Sell |
226,626
-44,884
| -17% | -$979K | 0.01% | 721 |
|
|
2016
Q3 | $6.46M | Hold |
271,510
| – | – | 0.01% | 696 |
|
|
2016
Q2 | $6.34M | Buy |
271,510
+59,734
| +28% | +$1.29M | 0.01% | 686 |
|
|
2016
Q1 | $3.99M | Hold |
211,776
| – | – | 0.01% | 726 |
|
|
2015
Q4 | $3.9M | Sell |
211,776
-60,514
| -22% | -$1.08M | 0.01% | 789 |
|
|
2015
Q3 | $4.47M | Hold |
272,290
| – | – | 0.01% | 757 |
|
|
2015
Q2 | $4.85M | Hold |
272,290
| – | – | 0.01% | 741 |
|
|
2015
Q1 | $4.86M | Buy |
272,290
+78,950
| +41% | +$1.25M | 0.01% | 763 |
|
|
2014
Q4 | $2.56M | Hold |
193,340
| – | – | 0.01% | 869 |
|
|
2014
Q3 | $2.28M | Hold |
193,340
| – | – | ﹤0.01% | 898 |
|
|
2014
Q2 | $2.47M | Hold |
193,340
| – | – | ﹤0.01% | 862 |
|
|
2014
Q1 | $2.61M | Buy |
193,340
+78,246
| +68% | +$1.03M | ﹤0.01% | 870 |
|
|
2013
Q4 | $1.38M | Sell |
115,094
-62,883
| -35% | -$743K | ﹤0.01% | 991 |
|
|
2013
Q3 | $2.09M | Hold |
177,977
| – | – | 0.01% | 909 |
|
|
2013
Q2 | $1.65M | Buy |
+177,977
| New | +$1.51M | ﹤0.01% | 930 |
|
Other funds holding BSX
Schroder Investment Management Group's BSX Position: Q2 2026 in Review
Schroder Investment Management Group reduced its Boston Scientific (BSX) stake by 35% in Q2 2026, selling an estimated $138M and leaving 4,708,211 shares worth $201M. The position accounts for 0.14% of the portfolio, ranked #139.
Schroder Investment Management Group first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $898M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Schroder Investment Management Group held 4,708,211 shares of Boston Scientific worth $201M as of Q2 2026.
- Schroder Investment Management Group sold 2,543,796 Boston Scientific shares in Q2 2026, an estimated $138M.
- Boston Scientific made up 0.14% of Schroder Investment Management Group's portfolio in Q2 2026, its #139 holding.
- Schroder Investment Management Group first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Schroder Investment Management Group's Boston Scientific position peaked at $898M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.